luminex corp (LMNX:NASDAQ GS)
Edward A. Ogunro Ph.D.
Independent Director, Chairman of Strategy & Development Committee and Member of Nominating & Corporate Governance Committee, Luminex Corporation
|Age||Total Calculated Compensation||This person is connected to 13 board members in 1 different organizations across 4 different industries.|
See Board Relationships
Dr. Edward A. Ogunro, also known as Ed, Ph.D., served as Chief Scientific Officer and Senior Vice President of Research & Development and Medical & Regulatory Affairs at Hospira Inc. from April 2004 to December 2007. Dr. Ogunro served as Vice President of Hospital Products Research and Development, Medical and Regulatory Affairs of Abbott Laboratories from 1999 to April 2004. He joined Abbott in 1982 as a Research Biochemist in the diagnostics division. Prior to Abbott's ...
12212 Technology BoulevardPhone: 512-219-8020
Austin, Texas 78727
Board Members Memberships*
Former Director, Member of Nominating & Governance Committee and Member of Compensation Committee
Independent Director, Chairman of Strategy & Development Committee and Member of Nominating & Corporate Governance Committee
University Of London
University Of London
University of Reading
Northwestern University, Feinberg School of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Justin C. Dearborn||Chief Executive Officer, President, Corporate Secretary, Director, Member of Executive Committee and Chief Executive Officer of Merge DNA|
Merge Healthcare Incorporated
|Robert A. Frist Jr.||Co-Founder, Chairman, Chief Executive Officer and President|
|Douglas C. Bryant||Chief Executive Officer, President and Director|
|John A. Krauetler||Chairman of The Board, Chief Executive Officer and President|
Meridian Bioscience, Inc.
|J. Boyd Douglas||Chief Executive Officer, President, Executive Director, Chief Executive Officer of Evident, LLC and President of Evident, LLC|
Computer Programs & Systems Inc.
|$630.0K||Compensation as of Fiscal Year 2014.|